|
1
|
Allen KL, Tschantz DR, Awad KS, Lynch WP
and DeLucia AL: A plant lignan, 3′-O-methyl-nordihydroguaiaretic
acid, suppresses papillomavirus E6 protein function, stabilizes p53
protein, and induces apoptosis in cervical tumor cells. Mol
Carcinog. 46:564–575. 2007.
|
|
2
|
Meyer GE, Chesler L, Liu D, Gable K,
Maddux BA, Goldenberg DD, Youngren JF, Goldfine ID, Weiss WA,
Matthay KK and Rosenthal SM: Nordihydroguaiaretic acid inhibits
insulin-like growth factor signaling, growth, and survival in human
neuroblastoma cells. J Cell Biochem. 102:1529–1541. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Meyers RO, Lambert JD, Hajicek N, Pourpak
A, Kalaitzis JA and Dorr RT: Synthesis, characterization, and
anti-melanoma activity of tetra-O-substituted analogs of
nordihydroguaiaretic acid. Bioorg Med Chem Lett. 19:4752–4755.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zur Hausen H: Papillomavirus infections –
a major cause of human cancers. Biochim Biophys Acta. 1288:F55–F78.
1996.
|
|
5
|
Narisawa-Saito M and Kiyono T: Basic
mechanisms of high-risk human papillomavirus-induced
carcinogenesis: roles of E6 and E7 proteins. Cancer Sci.
98:1505–1511. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhao J, Zhao Y, Chen W, Li YM and Bian XW:
The differentiation- inducing effect of Nordy on HPV-16
subgenes-immortalized human endocervical cells H8. Anticancer
Drugs. 19:713–719. 2008. View Article : Google Scholar
|
|
7
|
Bahnassy AA, Zekri AR, Alam El-Din HM,
Aboubakr AA, Kamel K, El-Sabah MT and Mokhtar NM: The role of
cyclins and cyclins inhibitors in the multistep process of
HPV-associated cervical carcinoma. J Egypt Natl Canc Inst.
18:292–302. 2006.PubMed/NCBI
|
|
8
|
Tsao YP, Huang SJ, Chang JL, Hsieh JT,
Pong RC and Chen SL: Adenovirus-mediated p21(WAF1/SDII/CIP1) gene
transfer induces apoptosis of human cervical cancer cell lines. J
Virol. 73:4983–4990. 1999.PubMed/NCBI
|
|
9
|
Hirano K, Hirano M, Zeng Y, Nishimura J,
Hara K, Muta K, Nawata H and Kanaide H: Cloning and functional
expression of a degradation-resistant novel isoform of p27Kip1.
Biochem J. 353:51–57. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Abbas T and Dutta A: p21 in cancer:
intricate networks and multiple activities. Nat Rev Cancer.
9:400–414. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen YX, Fang JY, Lu R and Qiu DK:
Expression of p21(WAF1) is related to acetylation of histone H3 in
total chromatin in human colorectal cancer. World J Gastroenterol.
13:2209–2213. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Richon VM, Sandhoff TW, Rifkind RA and
Marks PA: Histone deacetylase inhibitor selectively induces p21WAF1
expression and gene-associated histone acetylation. Proc Natl Acad
Sci USA. 97:10014–10019. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Giannoudis A and Herrington CS:
Differential expression of p53 and p21 in low grade cervical
squamous intraepithelial lesions infected with low, intermediate,
and high risk human papillomaviruses. Cancer. 89:1300–1307. 2000.
View Article : Google Scholar
|
|
14
|
Hietanen S, Lain S, Krausz E, Blattner C
and Lane DP: Activation of p53 in cervical carcinoma cells by small
molecules. Proc Natl Acad Sci USA. 97:8501–8506. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
De-Castro Arce J, Göckel-Krzikalla E and
Rösl F: Retinoic acid receptor beta silences human
papillomavirus-18 oncogene expression by induction of de novo
methylation and heterochromatinization of the viral control region.
J Biol Chem. 282:28520–28529. 2007.PubMed/NCBI
|
|
16
|
Deng Y, Lin C, Zheng J, Fu M, Liang X,
Chen J, Xiao P and Wu M: Overexpression of Bcl-2 partly inhibits
apoptosis of human cervical cancer SiHa cells induced by arsenic
trioxide. Chin Med J (In English). 113:84–88. 2000.PubMed/NCBI
|
|
17
|
Yoshinouchi M, Yamada T, Kizaki M, Fen J,
Koseki T, Ikeda Y, Nishihara T and Yamato K: In vitro and in vivo
growth suppression of human papillomavirus 16-positive cervical
cancer cells by E6 siRNA. Mol Ther. 8:762–768. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lagger G, Doetzlhofer A, Schuettengruber
B, Haidweger E, Simboeck E, Tischler J, Chiocca S, Suske G,
Rotheneder H, Wintersberger E and Seiser C: The tumor suppressor
p53 and histone deacetylase 1 are antagonistic regulators of the
cyclin-dependent kinase inhibitor p21/WAF1/CIP1 gene. Mol Cell
Biol. 23:2669–2679. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Allison SJ, Jiang M and Milner J:
Oncogenic viral protein HPV E7 up-regulates the SIRT1 longevity
protein in human cervical cancer cells. Aging. 1:316–327.
2009.PubMed/NCBI
|
|
20
|
Vaziri H, Dessain SK, Ng Eaton E, Imai SI,
Frye RA, Pandita TK, Guarente L and Weinberg RA: hSIR2(SIRT1)
functions as an NAD-dependent p53 deacetylase. Cell. 107:149–159.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yamakuchi M, Ferlito M and Lowenstein CJ:
miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci
USA. 105:13421–13426. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jenuwein T and Allis CD: Translating the
histone code. Science. 293:1074–1080. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Allison SJ and Milner J: Loss of p53 has
site-specific effects on histone H3 modification, including serine
10 phosphorylation important for maintenance of ploidy. Cancer Res.
63:6674–6679. 2003.PubMed/NCBI
|
|
24
|
Warnock LJ, Adamson R, Lynch CJ and Milner
J: Crosstalk between site-specific modifications on p53 and histone
H3. Oncogene. 27:1639–1644. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Eberharter A and Becker PB: Histone
acetylation: a switch between repressive and permissive chromatin.
Second in review series on chromatin dynamics. EMBO Rep. 3:224–229.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xiao H, Hasegawa T and Isobe K: p300
collaborates with Sp1 and Sp3 in p21(waf1/cip1) promoter activation
induced by histone deacetylase inhibitor. J Biol Chem.
275:1371–1376. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ohshima T, Suganuma T and Ikeda M: A novel
mutation lacking the bromodomain of the transcriptional coactivator
p300 in the SiHa cervical carcinoma cell line. Biochem Biophys Res
Commun. 281:569–575. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wilson AJ, Byun DS, Nasser S, Murray LB,
Ayyanar K, Arango D, Figueroa M, Melnick A, Kao GD, Augenlicht LH
and Mariadason JM: HDAC4 promotes growth of colon cancer cells via
repression of p21. Mol Biol Cell. 19:4062–4075. 2008. View Article : Google Scholar : PubMed/NCBI
|
